Онлайн КрасотаКаталог

Брошюра «Клинические исследования пептидных биорегуляторов» Электронная версия на английском языке — страница 11

Книги и пособия · 125 страниц · 0.7 МБ · Полное издание

Читать текстСкачать PDF
Bonothyrk® REFERENCES 1. Benevolenskaya L.I. Osteoporosis - an urgent problem of medicine // Osteoporosis and Osteopa- thy. - 1998. - №1 - 4-7pp. 2. Mikhailov E.E. Benevolenskaya L.N., Anikin S.G. et al. Osteoporosis and Osteopathy. 1999; 3: 2-6 3. RozhinskayaL.Ya. Systemic osteoporosis. M., 2001; with. 46-64 4. Chen XD, Shi S, Xu T, Robey PG, Young MF. Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res. 2002Feb;17(2):331-40 5. Clarke H., Anderson H. An Antagonist of Osteoclast Integrins Prevents Experimental Osteoporosis // J. Clin. Invest. Volume 99, Number 9, May 1997, 2059-2059 RECOMMENDATIONS FOR USE BONOTHYRK® is a complex of peptides obtained from the parathyroid glands of young animals. The extracted peptides have a selective effect on the cells of the parathyroid glands, normalize metab- olism in the cells of the parathyroid glands, and regulate the functions of bone tissue, especially in older women. A clinical study established the effectiveness of BONOTHYRK® in the prevention and complex treat- ment of patients with osteoporosis, including women over the age of 50. Bonothyrk® instructions: 1-2 capsules or tablets with meals 1-2 times a day. The duration of admin- istration is 30 days. It is advisable to repeat the course in 3-6 months. Do not use if: you suffer from individual intolerance to the components, pregnancy, breastfeeding. There were no side effects observed when using BONOTHYRK®. Store in a dry, dark place at a temperature from +2 to +25 ºС. Release form: 20 capsules or tablets containing 10 mg of BONOTHYRK®. Expiration date: 3 years from the date of manufacture. Responsible executor: A.A. Veretenko Deputy Director of the LLC «Medical Center of the St. Petersburg Institute of Bioregulation and Gerontology, SZO RAMS» for clinical work, Candidate of Medical Sciences (PhD in Medical Science), Associate Professor Executor: O.U. Raigorodsky Chief Physician of the LLC «Medical Center of the St. Petersburg Institute of Bioregulation and Gerontology, SZO RAMS», Candidate of Medical Sciences (PhD in Medical Science)

Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.

Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.